Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report.

Sahin F, Sercan Z, Ertan Y, Ocakci S, Ay E, Vural F, Yuksel E, Tombuloglu M, Saydam G.

Hematology. 2007 Dec;12(6):489-92.

PMID:
17852454
2.

Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.

Chen X, Zhang Y, Li Y, Lei P, Zhai Y, Liu L.

J Pediatr Hematol Oncol. 2010 Aug;32(6):501-3. doi: 10.1097/MPH.0b013e3181e413fa.

PMID:
20562652
3.

Sequential transformation of t(8;13)-related disease: a case report.

Roy S, Szer J, Campbell LJ, Juneja S.

Acta Haematol. 2002;107(2):95-7.

PMID:
11919389
4.

[8p11 myeloproliferative syndrome].

Li F, Zhai YP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Aug;21(4):1073-7. doi: 10.7534/j.issn.1009-2137.2013.04.050. Review. Chinese.

PMID:
23998615
5.

PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.

Chen J, Deangelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M, Duclos N, Cohen S, Adelsperger J, Okabe R, Coburn A, Galinsky I, Huntly B, Cohen PS, Meyer T, Fabbro D, Roesel J, Banerji L, Griffin JD, Xiao S, Fletcher JA, Stone RM, Gilliland DG.

Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14479-84. Epub 2004 Sep 24.

6.

The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

Macdonald D, Reiter A, Cross NC.

Acta Haematol. 2002;107(2):101-7. Review.

PMID:
11919391
7.

A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. A case report.

JabbarAl-Obaidi M, Rymes N, White P, Pomfret M, Smith H, Starczynski J, Johnson R.

Acta Haematol. 2002;107(2):98-100. Review.

PMID:
11919390
8.

FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.

Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA.

Nat Genet. 1998 Jan;18(1):84-7.

PMID:
9425908
9.

8p11 myeloproliferative syndrome: a review.

Jackson CC, Medeiros LJ, Miranda RN.

Hum Pathol. 2010 Apr;41(4):461-76. doi: 10.1016/j.humpath.2009.11.003. Review.

PMID:
20226962
10.

Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.

Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald DH, Aguiar RC, Gonçalves C, Hernandez JM, Jennings BA, Goldman JM, Cross NC.

Blood. 1998 Sep 1;92(5):1735-42.

11.

[Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].

Zhou F, Chen S, Chao H, Zhang R, Zhou M, Pan J.

Zhonghua Xue Ye Xue Za Zhi. 2015 Apr;36(4):291-6. doi: 10.3760/cma.j.issn.0253-2727.2015.04.006. Chinese.

PMID:
25916288
12.

Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.

Zhang WW, Habeebu S, Sheehan AM, Naeem R, Hernandez VS, Dreyer ZE, López-Terrada D.

J Pediatr Hematol Oncol. 2009 Nov;31(11):879-83. doi: 10.1097/MPH.0b013e3181b83fd0.

PMID:
19829149
13.

Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.

Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M, Strömbeck B, Olofsson T, Mitelman F, Johansson B.

Genes Chromosomes Cancer. 2001 Dec;32(4):302-10.

PMID:
11746971
14.

[Clinical pathological features of the 8p11 myeloproliferative syndrome].

Yan Z, Yang B, Wang QS, Wang LL, Han XP, Ren F, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Oct;18(5):1321-6. Chinese.

PMID:
21129285
15.

14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.

Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F, Chen J.

Blood. 2007 Jul 1;110(1):360-9. Epub 2007 Mar 27.

16.

Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.

Hu S, He Y, Zhu X, Li J, He H.

Pediatr Hematol Oncol. 2011 Mar;28(2):140-6. doi: 10.3109/08880018.2010.528170. Epub 2011 Jan 8. Review.

PMID:
21214407
17.

Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.

Roumiantsev S, Krause DS, Neumann CA, Dimitri CA, Asiedu F, Cross NC, Van Etten RA.

Cancer Cell. 2004 Mar;5(3):287-98.

18.

Identification of four new translocations involving FGFR1 in myeloid disorders.

Sohal J, Chase A, Mould S, Corcoran M, Oscier D, Iqbal S, Parker S, Welborn J, Harris RI, Martinelli G, Montefusco V, Sinclair P, Wilkins BS, van den Berg H, Vanstraelen D, Goldman JM, Cross NC.

Genes Chromosomes Cancer. 2001 Oct;32(2):155-63.

PMID:
11550283
19.

The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.

Goradia A, Bayerl M, Cornfield D.

Int J Clin Exp Pathol. 2008 Jan 1;1(5):448-56.

20.

Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases.

Wong WS, Cheng KC, Lau KM, Chan NP, Shing MM, Cheng SH, Chik KW, Li CK, Ng MH.

Leuk Res. 2007 Feb;31(2):235-8. Epub 2006 Jun 13.

PMID:
16777224

Supplemental Content

Support Center